Cargando…
Availability of Essential Medicines for Pediatric Oncology in Armenia
BACKGROUND: One of the main contributors in low survival rate in LMIC is the lack of availability of cancer medications for curative, supportive and palliative care. In many developing countries access to cytotoxic medicine is a major challenge. The information about the availability of essential me...
Autores principales: | Simonyan, Tamara, Papyan, Ruzanna, Danielyan, Samvel, Sargsyan, Lilit, Grigoryan, Varduhi, Topchyan, Hakob, Azaryan, Arpina, Tananyan, Armen, Muradyan, Armen, Tamamyan, Gevorg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948909/ https://www.ncbi.nlm.nih.gov/pubmed/31030465 http://dx.doi.org/10.31557/APJCP.2019.20.4.991 |
Ejemplares similares
-
LINC-14. TREATMENT OF PEDIATRIC CNS TUMORS IN ARMENIA. 10 YEARS OF EXPERIENCE IN A 29 YEARS OLD RESOURCE-LIMITED SETTING
por: Harutyunyan, Martin, et al.
Publicado: (2020) -
Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia
por: Arakelyan, Jemma, et al.
Publicado: (2021) -
Younger age and previous exposure to radiation therapy are correlated with the severity of chemotherapy-induced thrombocytopenia
por: Mkhitaryan, Sergo, et al.
Publicado: (2019) -
LINC-13. THE STATE OF PEDIATRIC NEURO-ONCOLOGY IN ARMENIA
por: Bardakhchyan, Samvel, et al.
Publicado: (2020) -
Overview of Cancer Control in Armenia and Policy Implications
por: Bedirian, Karen, et al.
Publicado: (2022)